LIN
Linde Plc
NASDAQ · Basic Materials · Chemicals - Specialty · GB
$500.57
−0.26%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 35.4B | 34.0B | 33.0B | 32.9B | 33.4B |
| Cost of Revenue | 22.1B | 21.2B | 20.9B | 21.3B | 23.7B |
| Gross Profit | 13.3B | 12.8B | 12.1B | 11.5B | 9.7B |
| Operating Expenses | |||||
| R&D Expense | 146.0M | 147.0M | 150.0M | 146.0M | 143.0M |
| SG&A Expense | 3.6B | 3.4B | 3.3B | 3.3B | 3.1B |
| General & Admin Expense | 893.0M | — | 2.0B | — | — |
| Selling & Marketing Expense | — | — | 1.3B | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 3.7B | 3.6B | 3.5B | 3.4B | 3.3B |
| Cost and Expenses | 25.8B | 24.7B | 24.4B | 24.7B | 26.9B |
| Operating Income (EBIT) | 9.6B | 9.3B | 8.6B | 8.1B | 6.5B |
| Non-Operating | |||||
| Interest Income | — | 209.0M | 228.0M | 197.0M | 117.0M |
| Interest Expense | 268.0M | 464.0M | 572.0M | 488.0M | 192.0M |
| Net Interest Income | (268.0M) | (255.0M) | (344.0M) | (291.0M) | (75.0M) |
| Other Non-Op Income/Expense | (104.0M) | (207.0M) | 144.0M | 50.0M | (745.0M) |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 9.5B | 9.0B | 8.7B | 8.2B | 5.7B |
| Income Tax Expense | 2.1B | 2.0B | 2.0B | 1.8B | 1.4B |
| Bottom Line | |||||
| Net Income | 7.2B | 6.9B | 6.6B | 6.2B | 4.1B |
| Earnings from Cont. Ops | 7.4B | 7.1B | 6.7B | 6.3B | 4.3B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 7.2B | 6.9B | 6.6B | 6.2B | 4.1B |
| Per Share | |||||
| Basic EPS | $15.56 | $14.67 | $13.71 | $12.70 | $8.30 |
| Diluted EPS | $15.48 | $14.59 | $13.62 | $12.59 | $8.23 |
| Revenue Per Share | $76.64 | $72.89 | $68.94 | $67.30 | $66.76 |
| Shares | |||||
| Basic Shares Outstanding | 462.5M | 466.2M | 478.8M | 488.2M | 499.7M |
| Diluted Shares Outstanding | 464.5M | 468.7M | 482.1M | 492.3M | 504.0M |
| Profitability Metrics | |||||
| EBITDA | 13.4B | 13.0B | 12.4B | 11.9B | 10.7B |
| D&A | 3.8B | 3.8B | 3.8B | 3.8B | 4.2B |
| EBIT | 9.6B | 9.3B | 8.6B | 8.1B | 6.5B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026